Treatment of a case of COVID-19 by intravenous immunoglobulin

https://doi.org/10.1016/j.jgar.2020.12.003Get rights and content
Under a Creative Commons license
open access

Highlights

  • Thisreport is a case of COVID-19 treated with IVIG.

  • IVIg may be an adjunctive therapy for COVID-19 with appropriate antibiotics and antivirals.

  • Intravenous immunoglobulin (IVIg) treatment can be life-saving in patients with severe COVID-19.

Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. As of today, no specific treatment has been found COVID-19. İntravenous immunoglobulin (IVIG) is a widely used therapy to prevent life-threatening infections in patients with primary and secondary immune deficiencies and autoimmune/inflammatory conditions. IVIG administration could be beneficial in the treatment of patients with severe COVID-19. In this respect, this presentation aimed to report a case of COVID-19 treated with IVIG.

Keywords

COVID-19
Coronavirus
intravenous immunoglobulin

Cited by (0)